NCT01715779View on ClinicalTrials.gov

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Hepatitis C
Interventions
DRUG

Eltrombopag

Eltrombopag exposure

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01715779 - Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies | Biotech Hunter | Biotech Hunter